Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
André Scheen
Topics & Concepts
EmpagliflozinMedicineCanagliflozinType 2 Diabetes MellitusDapagliflozinMetforminDiabetes mellitusType 2 diabetesHeart failureKidney diseaseInternal medicineEndocrinologyCardiologyDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes